Delay to Diagnosis in Digestive Cancerology by the General Practitioner Related to Covid-19 Pandemic Confinement

Delay to Diagnosis and Management in Digestive Cancerology by the General Practitioner Within the City-hospital Network in the Context of Confinement Related to the Covid-19 Pandemic

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06118125

Enrollment

376

Registered

2023-11-07

Start date

2019-06-01

Completion date

2022-09-01

Last updated

2023-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Cancer, Diagnosis, General Practitioner, Neoplasm, Liver, Neoplasms, Colorectal, Neoplasms Pancreatic, Pandemic, COVID-19

Keywords

digestive cancer, covid

Brief summary

Objective: the pre-hospital management of cancers is little known in General Medicine. The first lockdown related to the COVID-19 pandemic led to the closure of health facilities. Investigators were interested in the diagnosis and care pathway of digestive cancers in post-confinement in General Medicine in Nouvelle-Aquitaine.

Detailed description

Method: patient records discussed in Digestive Oncology CPR of Bordeaux University Hospital for the first time from June 1 to August 31, 2020 and over the same period in 2019 were included. A questionnaire on the dates of the first symptoms, first consultation with the general practitioner, imaging examination and access to the specialist was sent to the general practitioner. The primary outcome was time from onset to date of first MDT.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* residing in New Aquitaine and * whose general practitioner practiced in New Aquitaine * malignant tumors of the esophagus, stomach, small intestine, colon, recto-sigmoid junction, rectum, anus and anal canal, liver and intrahepatic bile ducts, extrahepatic bile ducts, gallbladder and pancreas. * to have had at least one consultation or hospitalization in the digestive pole of the Bordeaux University Hospital within 6 months after the MDT.

Exclusion criteria

* Patients under 18 years of age, * who had already had a MDT for this cancer, * whose date of first MDT was outside the inclusion dates, * whose new cancer was a digestive metastasis of a primary of another location, * who did not have French health insurance

Design outcomes

Primary

Measure	Time frame	Description
time from date of first symptoms of cancer to the date of first MDT	DAYS	time from date of first symptoms of cancer to the date of first MDT

Secondary

Measure	Time frame	Description
frequency of different types of cancer,	at inclusion	PERCENTAGE of each type of cancers in this study
overall survival.	MONTHS, time from from date of first symptoms to date of death	overall survival.
stage of pathology by type of cancer,	at inclusion	stage of pathology by type of cancer according to TNM classification (tumor, node, metastatic status)
time from date of first symptoms to first imaging or specific examination,	DAYS	difficulties in referral to imaging,
time from date of first symptoms to consultation with a specialist,	DAYS	difficulties in referral to a specialist,
time from date of first symptoms to date of first consultation with a general practitioner,	DAYS	time from date of first symptoms to date of first consultation with a general practitioner,

Countries

France

Outcome results